@article{7260b922bb6b4a14b096e4515c35d903,
title = "Deregulation of E-Cadherin and MTA2 in Tamoxifen Resistant Breast Cancer Cells [Abstract \#982.11]",
author = "Hathaway, \{Millie Mae\} and Louie, \{Maggie C.\}",
note = "Tamoxifen is an antiestrogen often used to treat hormone responsive breast cancer. It is a selective estrogen receptor modulator that inhibits breast cancer cell growth by competing with estrogen for receptor binding. Although tamoxifen has been successful in the treatment of breast cancer, prolonged usage of the drug often leads to the development of acquired resistance in which tumors become non-responsive.",
year = "2012",
language = "American English",
volume = "26",
journal = "The Journal of the Federation of American Societies for Experimental Biology (FASEB)",
}